LA Function and Dimensions As Predictors of Disease Activity in RA
ConditionRhematoid Arthritis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
the aim of this study is to
* describe subclinical echocardiographic changes of the LA (dimensions and function) in patients with rheumatoid arthritis. * evaluate the correlation between Rheumatoid arthritis activity and subclinical structural changes of LA. * determine the association of LA volume index and atrial fibrillation or HFpf in RA patients. * apply Musculoskeletal Ultrasound detected synovitis to be correlated with cardiac function.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with known history of atherosclerotic heart disease.
Patients with overlap syndrome.
Patients with hypothyroidism, Cushing's syndrome, anemia, and severe hepatic or renal dysfunction
Trial design
Treatments tested in this trial
- echocardography
- musculoskeletal ultrasonography
- lipid profile test
- C reactive protein
- Complete blood count CBC
- Erythrocyte sedimentation rate (ESR).
- x ray of the hand
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov